Omid Hamid, MD, compares the responses of patients with melanoma on single-agent immunotherapy treatment to those on combination therapy treatments.
Omid Hamid, MD
Advertisement
Articles by Omid Hamid, MD
Dr. Omid Hamid discusses some toxicities that come from combination immunotherapies
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Navigation Boosts Cascade Genetic Testing in Relatives of BRCA Carriers
2
Multidisciplinary Support for Patients with Metastatic Triple-Negative Breast Cancer
3
Managing Oral and Ocular Toxicities in Metastatic Triple-Negative Breast Cancer
4
FDA Approves Atezolizumab Plus Chemo for Stage 3 dMMR Colon Cancer
5